FDA approves Parkinson’s drug based on University of Virginia research
The Food and Drug Administration has approved a new Parkinson’s disease drug based on research by University of Virginia scientists that could help patients control symptoms with a once-daily pill, UVA Health announced last week. Tavapadon, sold under the …